The better diversity of antibodies you have against a target, you get compounding synergistic protection and protection against mutational escape on the part of

The better diversity of antibodies you have against a target, you get compounding synergistic protection and protection against mutational escape on the part of the virus. And a natural virus with all it's parts is going to elicit a more diverse collection of antibodies than a spike-protein targeted vaccine. This should be absolutely unsurprising.